InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

MUT Insider Trading

Insider Ownership Percentage: 0.86%
Insider Buying (Last 12 Months): £34,825.68
Insider Selling (Last 12 Months): GBX 0

Murray Income Trust Insider Trading History Chart

This chart shows the insider buying and selling history at Murray Income Trust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Murray Income Trust Share Price & Price History

Current Price: GBX 835.46
Price Change: ▼ Price Decrease of -0.541 (-0.06%)
As of 04/19/2024 05:37 PM ET

This chart shows the closing price history over time for MUT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Biden’s $374B Giveaway Into This Sector
From DTI   |   Ad
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

Murray Income Trust Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/25/2024Angus FranklinInsiderBuy4,206GBX 828£34,825.68
3/3/2023Peter TaitInsiderBuy2,000GBX 873£17,460
9/23/2022Neil RoganInsiderBuy2,022GBX 791£15,994.02
4/27/2022Neil RoganInsiderBuy1,079GBX 875£9,441.25
11/4/2021Alan GilesInsiderBuy2,023GBX 911£18,429.53
6/10/2021Merryn SomersetInsiderBuy2,185GBX 915£19,992.75
See Full Table
Secret Bull Market Starts in This Unusual Sector
From Altimetry   |   Ad
"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.
Click for my No. 1 investment, all free of charge, click here. 

SEC Filings (Institutional Ownership Changes) for Murray Income Trust (LON:MUT)

46.82% of Murray Income Trust stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Murray Income Trust logo
Murray Income Trust PLC is a closed ended equity mutual fund launched and managed by Aberdeen Fund Managers Limited. It is co-managed by Aberdeen Asset Managers Limited. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in dividend paying growth stocks of large-cap companies. It employs fundamental analysis with a combination of bottom-up and top-down stock picking approaches, focusing on such factors as good management, strong cash flow, and a sound balance sheet to build its portfolio. The fund benchmarks the performance of its portfolio against the FTSE All-Share Index. Murray Income Trust PLC was formed in 1923 and is domiciled in the United Kingdom.
Read More on Murray Income Trust

Today's Range

Now: GBX 835.46
Low: 826.72
High: 838.67

50 Day Range

MA: GBX 827.01
Low: 812
High: 844

52 Week Range

Now: GBX 835.46
Low: 766.60
High: 884.25

Volume

210,209 shs

Average Volume

164,262 shs

Market Capitalization

£894.36 million

P/E Ratio

1,160.36

Dividend Yield

4.99%

Beta

0.8

Who are the company insiders with the largest holdings of Murray Income Trust?

Murray Income Trust's top insider investors include:
  1. Angus Franklin (Insider)
  2. Neil Rogan (Insider)
  3. Peter Tait (Insider)
Learn More about top insider investors at Murray Income Trust.
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>